novartis india q3 net profit soars 44 per cent n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Novartis India Q3 Net Profit Soars 44 Per Cent at Rs 187.4 Million PowerPoint Presentation
Download Presentation
Novartis India Q3 Net Profit Soars 44 Per Cent at Rs 187.4 Million

Loading in 2 Seconds...

play fullscreen
1 / 2

Novartis India Q3 Net Profit Soars 44 Per Cent at Rs 187.4 Million - PowerPoint PPT Presentation


  • 3 Views
  • Uploaded on

Read more about Novartis India Q3 net profit soars 44 per cent at Rs 187.4 million on Business Standard. Novartis India also announced the appointment of Jawed Zia as vice chairman and managing director of the company effective March 1, 2018

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Novartis India Q3 Net Profit Soars 44 Per Cent at Rs 187.4 Million' - priya32438


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
novartis india q3 net profit soars 44 per cent

Novartis India Q3 net profit soars 44 per cent

at Rs 187.4 million

Novartis India today reported a 43.82 per cent increase in net profit at Rs 187.4

million for the third quarter ended December 2017.

The company had posted a net profit of Rs 130 crore in the same period of the

previous fiscal.

Total income of the company during the period under review stood at Rs 1705.5

million compared with Rs 1794.6 million in the same period of the last fiscal,

Novartis India said in a BSE filing.

The board of directors of Novartis India also announced the appointment of

Jawed Zia as vice chairman and managing director of the company effective

March 1, 2018.

jawed zia is currently head pharmaceuticals

Jawed Zia is currently Head Pharmaceuticals, Novartis India.

Zia succeeds Ranjit Shahani who holds this position until February 28, 2018.

Shares of Novartis India settled 1.04 per cent down at Rs 650.50 apiece on BSE

today.

Article By - Business Standard